The Risk of Fracture with Taking Alpha Blockers for Treating Benign Prostatic Hyperplasia.
Joongyub Lee, Nam Kyoung Choi, Sun Young Jung, Ye Jee Kim, Jong Mi Seong, Seung June Oh, Byung Joo Park
J Prev Med Public Health. 2009;42(3):165-170.     DOI:
Citations to this article as recorded by Crossref logo
Risk for Hip Fracture due to Alpha Blocker Treatment in Korean Women: National Health Insurance Database Study
Gi H. SEO, Sung R. SHIM, Hwan W. LEE, Jin H. KIM, Dong-Il CHUN, Hyun J. KIM, Hyun Y. LEE, Jae H. KIM
LUTS: Lower Urinary Tract Symptoms.2018; 10(2): 175.     CrossRef
Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study
Chao-Lun Lai, Raymond Nien-Chen Kuo, Ho-Min Chen, Ming-Fong Chen, Kinwei Arnold Chan, Mei-Shu Lai
British Journal of Clinical Pharmacology.2015; 80(5): 1208.     CrossRef
The Association of Alpha-Blockers and 5-Alpha Reductase Inhibitors in Benign Prostatic Hyperplasia With Fractures
Sian Yik Lim, Pavis Laengvejkal, Ragesh Panikkath, Kenneth Nugent
The American Journal of the Medical Sciences.2014; 347(6): 463.     CrossRef
Alpha-adrenergic blocker mediated osteoblastic stem cell differentiation
Yoon Jung Choi, Jue Yeon Lee, Seung Jin Lee, Chong-Pyoung Chung, Yoon Jeong Park
Biochemical and Biophysical Research Communications.2011; 416(3-4): 232.     CrossRef
Risk of fractures associated with treatment for benign prostate hyperplasia in men
P. Vestergaard, L. Rejnmark, L. Mosekilde
Osteoporosis International.2011; 22(2): 731.     CrossRef
Databases in Asia and Record-Linkage
Kiyoshi KUBOTA
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku.2011; 16(1): 27.     CrossRef